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 ABSTRACT 
The increase in access to and use of medication worldwide has led to ubiquitous and 
persistence presence of pharmaceuticals in the natural environment. Major risks from 
environmental contamination due to drugs include death of organisms, habitat loss, mutation, 
and rise of antigen-resistant microbes. India has suffered enormous regional ecological damage 
from pharmaceutical contamination. Green chemistry approaches and environmentally-friendly 
pharmaceuticals exist, but they currently do not enjoy popular support from the pharmaceutical 
industry or consumers.   
By conducting a public survey in Indore, India, this research attempts to understand 
whether consumers would support environmentally-friendly pharmaceuticals. The survey 
measures environmental concern, self-estimated knowledge, risk perception, and consumer 
intention. Statistical analyses indicate that environmental concern, self-estimated knowledge, and 
risk perception are each positively correlated with consumer intention. Results show that most 
people demonstrate environmentally-friendly consumer intention; and environmental concern 
was found to be its strongest indicator of consumer intention.  
Keywords: environmental pollution; pharmaceuticals in the environment; sustainable 
pharmaceuticals; Indian pharmaceutical industry; Indian consumers 
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CHAPTER 1 
INTRODUCTION 
Environmental degradation resulting from pharmaceutical pollution is an important 
concern, especially in a developing country like India. The following text discusses the state of 
pharmaceutical industry in the world and in India. Projections about the growth of the industry 
are described. These projections implicate the establishment of more manufacturing units and, 
subsequently, greater ingress of pharmaceutical drugs in the natural and built environment.  
Rise of pharmaceuticals  
The steady increase in availability and accessibility of medication throughout the world is 
a great achievement in recent history of healthcare. The global pharmaceutical industry is 
growing continuously, with regular new advancements both in currently available drugs and in 
research and development (R&D) for new drugs. The production value of the global 
pharmaceutical industry has increased from USD 651.4 billion in 2006, to USD 870.1 billion in 
2010, and USD 996.9 in 2014 (International Federation of Pharmaceutical Manufacturers & 
Associations, 2017).  India plays an important role in the multi-billion-dollar industry, both as a 
production region and as a consumer market.  The country‘s pharmaceutical industry is ranked 
3
rd
 in terms of volume, and 13
th
 in terms of value (FICCI, 2017). India is also a major exporter of 
pharmaceutical drugs, supplying about 10% of the total global production and exporting 
pharmaceuticals to regions comprising United States, European Union, and sub-Saharan Africa 
(U.S. International Trade Commission, 2018).   
The Annual Report (2016-17) of Department of Pharmaceuticals, India, mentions plans 
to increase manufacturing of active pharmaceutical ingredients (APIs) or bulk drugs within India 
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to strengthen self-reliance. This would help to maintain competitiveness of Indian industries and 
ensure low-cost healthcare. According to the report, the Government of India is also promoting 
clusters of pharmaceutical manufacturing units through introduction of programs like ―Cluster 
Development Program for Pharma Sector‖ (CDP-PS) and in the future, creation of bulk drug and 
API parks (Department of Pharmaceuticals, 2017; FICCI, 2017). Currently, the majority of 
pharmaceutical manufacturing clusters are located in the Indian states of Telangana, Andhra 
Pradesh, Gujarat, Punjab and Haryana, as shown in Figure 1. The Hyderabad and 
Vishakhapatnam clusters in states of Telangana and Andhra Pradesh are known for their bulk 
drug and active pharmaceutical ingredients manufacturing units, while more specialized 
formulations like birth control pills are generally produced near the Ahmedabad cluster in 
Gujarat (Global Business Reports, 2017).  The country plans to invest $27.3 million to establish 
ten new pharmaceutical clusters in the near future, projected to reduce cost of medication by up 
to 25% (Lane, 2015). These industrial clusters are expected to receive subsidized land and 
utilities, with shared infrastructure like effluent treatment plants, discharge pipelines, and quality 
assurance checks (FICCI, 2017).  It is thus evident that production and consumption of 
pharmaceuticals will continue to rise in near future, and India is expected to become a 
progressively important manufacturing center for the global industry.  
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Figure 1: Map of India showing major pharmaceutical clusters (Invest India, 2018) 
Pharmaceuticals in the environment  
The high volume and geographically widespread use of pharmaceuticals has led to the 
introduction and persistent presence of medicines and drugs in the natural environment 
(Daughton & Ternes, 1999; Fent, Weston & Caminada, 2006; Kümmerer, 2008). There is a 
complex network of processes and pathways that release pharmaceuticals, chemicals and active 
drugs into the natural and human-made external environment. A review article of publications 
that quantitatively analyzed pharmaceuticals in water in the U.S. states that pharmaceuticals have 
been detected drinking water, surface water, groundwater, wastewater, and municipal biosolid 
waste (Deo & Halden, 2013). Figure 2 and 3 depict the pathways of introduction of 
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pharmaceuticals into natural and built water streams. In addition to water systems, these 
contaminants are also absorbed into soil and found in bodies of plants and animals (Daughton, 
2016; Deo & Halden, 2013; Kümmerer, 2010).  
 
Figure 2: Pathways of introduction of pharmaceuticals into natural and built environment (Deo & 
Halden, 2013) 
The pathways through which pharmaceuticals enter the environment are described in the 
following paragraphs, along with information about the damage they could cause to human 
beings and other living organisms. In subsequent sections, strategies for control and remediation 
of pharmaceutical pollution, their merits and their demerits are briefly discussed. The most 
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effective long-term solution presented here is the widespread use of sustainable or 
environmentally-friendly pharmaceuticals. 
 
Figure 3: The flow of pharmaceuticals (Granberg, 2015) 
Daughton (2016) classifies the introductory pathways of pharmaceuticals (see Figures 2 
and 3) into the environment into two categories: upstream, and downstream. The upstream 
pathway of pharmaceutical contamination is often short, and releases concentrated active drugs 
into the external environment – these include the many kinds of large-scale negligent storage and 
disposal practices like waste elimination from manufacturing industries, or hospitals. The 
downstream pathway, in contrast, releases lower concentration of active drugs into the 
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environment through ways of diluted discharge from personal excretion, washing, flushing of 
unwanted medicine, landfill leaching, or wastewater discharge. Even though these bioactive 
chemicals travel in waste streams and eventually get diluted, the continual inflow from 
aforementioned sources creates a persistent presence of active pharmaceutical chemicals in trace 
quantities in the ambient environment (Daughton, 2016).   
The ecological life cycle of pharmaceuticals has also been studied over the years. As the 
animal or human body only absorbs a fraction of the pharmaceutical drug ingested, a large and 
therefore unabsorbed amount of the drug is excreted. Farre, Perez, Kantiani & Barcelo (2008) 
studied the ecotoxicological effect of 42 common pharmaceuticals, and found that on average, 
about 50% of the prescribed drug was not metabolized, and 70% of the parent pharmaceutical 
compound was excreted by the patient. In many cases, the individual low concentrations of 
active pharmaceutical compounds in the environment interact with each other and/or with other 
chemicals like chlorine to create compounds or mixtures, often called ―drug cocktails‖, that are 
potentially more toxic than the parent compounds (Farre et al., 2008; Sirés & Brillas, 2012).  
Once into the external natural environment, the active pharmaceutical drugs and chemical 
compounds could undergo transformation in presence of microbes, sunlight, and other chemicals, 
causing metabolites to disintegrate or give rise to new toxic and persistent byproducts that further 
complicate the assessment of risk from combined ambient exposure to these contaminants 
(Daughton, 2016; Kümmerer, 2007; Löffler, Römbke, Meller & Ternes, 2005). The 
concentration and toxicity of a particular pharmaceutical in the environment can become difficult 
to quantify due to continuous uptake by soil and organisms, bio-concentration, and 
transformation (Daughton, 2003). Despite multiple studies spanning time and distance, the full 
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ecological implications of pharmaceuticals in the environment is not fully known or understood 
(Fent et al., 2006).  
The first studies in the wide field of environmental contamination by pharmaceuticals 
were published in the late 1940s. These studies specifically explored increase in microbial 
resistance due to antibiotics in the environment (Barber, 1947; Miller, 1948). Later studies 
explored other pathways, contaminants, concentrations, environmental effects, and implications 
– these included topics like ecosystem impacts of veterinary drugs (Coats et al., 1976), steroid 
pollution in wastewater streams (Tabak et al., 1981), pharmaceuticals in water supply (Raloff, 
1998), uptake by plants and bio-concentration (Crowdy and Jones, 1956), along with risk 
assessment and environmental assessments of pharmaceutical pollutants (Bloom and Matheson, 
1993). Many studies, across geographical regions, contemporaneously found the presence of 
pharmaceutical and personal care products in water and in bodies of organisms.  An overview of 
the available transdisciplinary literature indicates that the studies come from diverse but 
overlapping fields of chemistry, chemical engineering, pharmacology, healthcare, veterinary 
medicine, water resources research, environmental studies, environmental health, toxicology, 
behavioral sciences and other such fields, comprising journal articles, conference papers, books, 
government reports, and industry guidelines. This thesis explores the concerns surrounding 
pharmaceutical contamination through social and behavioral science, specifically within the field 
of human-environment relations.  
Ecological damage due to pharmaceuticals 
There is mounting evidence to indicate the presence of pharmaceutical chemicals across 
the globe and ecological disturbance thus caused. Sub-therapeutic quantities of pharmaceuticals 
and their by-products in the environment can cause stress and serious damage to non-target 
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organisms. Other long-term environmental stressors that interact with active pharmaceuticals 
include heavy metals, persistent organic pollutants (POPs), trace chemicals, detergents, 
pesticides, personal care products and make-up, micro-pollutants, and endocrine disruptors.   
The presence of pharmaceuticals and related active chemicals in the environment have 
been conclusively proven to be responsible for ecological damage in multiple instances. One of 
the earliest studied consequence of pharmaceuticals in the environment was the emergence of 
antibiotic resistant bacteria. Many broad-spectrum antibiotics have been gendered ineffective due 
to strengthening antimicrobial resistance, or AMR (Ventola, 2015). This has implications for the 
field of medicine, as previously effective drugs become useless, and new alternatives are slow to 
transition from R&D labs to availability in the healthcare sector. The significant relationship 
between AMR and public health at a global level is well-recognized. The Centre of Disease 
Control and Prevention (CDC, 2013) recognized the present situation as ‗post-antibiotic era‘, and 
World Health Organization reported that AMR is risking humankind‘s ability to treat even the 
most common infections. The UK Government‘s independent review on AMR estimates that 10 
million lives per year and 10 trillion USD worth of economic output would be at risk due to 
drug-resistant infections by 2050 (Tackling Drug-Resistant Infections Globally, 2016).  
Similarly, overuse of veterinary drugs, especially in industrialized farming in the U.S. has 
been found to discharge unsafe quantities of pharmaceuticals into the surroundings. Animals 
reared on large farms for food in industrialized feedlots, also called Concentrated Animal 
Feeding Operations or CAFOs, are often treated regularly with antibiotics to prevent disease 
outbreaks, and growth hormones for early maturation (CDC, 2013). The subsequent entry and 
presence of pharmaceuticals from veterinary uses have been verified to cause drug-resistance in 
micro-organisms. The resistant micro-organisms are then transmitted to humans through 
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fertilizer, meat, groundwater, or surface water and can limit immunity in human beings (Michael, 
Dominey-Howes & Labbate, 2014).   
Steroid hormones meant for human consumption have also been detected in hazardous 
concentrations in the environment. Steroid estrogens, in particular, have been known to cause 
causing feminization of male fish, development of intersex characteristics, decreased fertility, 
and developmental abnormalities because of endocrine disruption in various species of fish and 
snails (Jobling et al., 2004; Silva, Otero & Esteves, 2012).   
World Health Organization‘s report on pharmaceuticals on drinking water (WHO, 2012) 
mentions that though the presence of trace quantities of pharmaceuticals in drinking water might 
not directly risk human health, it is a cause of concern for water safety management as it might 
cause indirect microbial and chemical hazards. According to the report, pharmaceuticals enter 
drinking water sources from groundwater, landfill leaching, and surface runoff, as most water 
treatment facilities do not have adequate infrastructure to filter out trace concentrations of 
pharmaceuticals. The report consists of data from the UK, US, and Australia.  
The uptake and bioconcentration of pharmaceuticals in soil and various plants has also 
been studied. Pharmaceuticals enter soil through groundwater, insufficiently treated sewage and 
manure, and are subsequently taken up by plants. Their effect on plants is seen as inhibition in 
branching, depressed growth, and bioaccumulation of chemicals, and reduction in crop yields 
(Jjemba, 2002).   
Ecological damage in India due to pharmaceuticals 
The entire Indian subcontinent, including India, Pakistan and Bangladesh, has seen loss 
of biodiversity due to pharmaceutical poisoning of scavenger animals like vultures. In 1990s, 
declining vulture populations spurred studies that found that diclofenac, a non-steroidal anti-
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inflammatory drug was ingested by vultures that ate carcasses of treated animals caused renal 
failure, leading to eradication of the species in cities like New Delhi (Green et al., 2004; Oaks et 
al., 2004; Schultz et al, 2004). In India, pharmaceutical pollution is conspicuous in news reports 
about large-scale loss of biodiversity in lakes near urban or industrial areas. Medhi and Sewal 
(2012) estimate the contamination in India to be almost 150 times the level of those found in 
developing countries. The length of polluted waterways in India reportedly doubled in the five-
year period from 2009-2014 (Vashishtha, 2015). API and bulk drug manufacturing in India is 
concentrated in a few locations in the country (see Figure 1), including the cities of Hyderabad, 
Telangana and Vishakhapatnam, Andhra Pradesh. The industrial areas in and around these two 
cities in southern India have borne the worst environmental damage due to pharmaceuticals 
among all other clusters in the country. Waterways along the periphery of Hyderabad, including 
Iska Vagu stream shown in Figure 4 and the Musi river, are heavily polluted with pharmaceutical 
effluents. In one of the many sporadic instances of acute pharmaceutical discharge, toxic leakage 
of a pharmaceutical solvent into Gandigudem lake in the district of Hyderabad in October 2017 
caused the death of 2.3 million fish, as seen in Figure 5, in the lake (Sangareddy, 2017). Dead or 
dying animals like fish and amphibians are a common sight, along with viscous white and brown 
foam, a classic indication of polluted water. Some waterbodies show change in the color of water 
to red or green due to toxins or heavy metal compounds (Ecostorm, 2016).   
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Figure 4: Polluted Iska Vagu stream, near Hyderabad, India (Kumar, 2008) 
 
Figure 5: Dead fish in Gandigudem Lake, Hyderabad, India (Nitin B., 2017) 
The extent of ecological damage in Hyderabad due to drug manufacturing prompted the 
Ministry of Environment and Forests (MoEF) to ban the expansion of industries in the area in 
2010 and in 2013. As early as 2004, Greenpeace reported the adverse effect of ambient drugs and 
chemicals on people, animals, crops, and the land around these industrial clusters (Ecostorm, 
2016). Recent studies by Ecostorm (2016) have found superbugs and drug-resistant bacteria in 
Musi river near suburban Hyderabad.  
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The communities residing in areas near drug manufacturing clusters have suffered long-
term damage. The same streams that carry effluent discharge from industries are the main source 
of drinking water for many villages and settlements downstream. In these communities, children 
have been reported to have congenital defects to due overexposure to toxic effluents. Adults and 
children alike have developed chronic ailments that do not respond to conventional treatment 
(Ecostorm, 2016). The Center for Disease Dynamics, Economics and Policy, Washington report 
that an estimated 58,000 newborn babies died in 2013 in India as a result of drug-resistant 
infections (CDDEP, 2015).  The residual effects of exposure remain in place, even though 
manufacturing units are now required by law to treat and purify all wastewater before its release 
into the surroundings. The expected growth of pharmaceutical industry in India and the extent of 
degradation that has already been caused necessitates that all future growth of the industry is 
managed in a way that gradually restores the environment by eliminating pollutants while 
preventing any further degradation.  
Managing pharmaceutical pollution 
It is imperative to control the quantities and types of pharmaceuticals allowed to enter the 
natural environment and remove the existing compounds to put a check to environmental 
contamination due to pharmaceutical pollution. Even after a pharmaceutical compound‘s ill-
effects have come to light, it often takes a long time to systematically remove the active chemical 
stressor or pharmaceutical from the environment. Polychlorinated biphenyls (PCBs), now 
recognized as persistent pollutants, were known to be associated with severe health problems 
since 1899. However, they were only banned in the European Union after about 100 years, in 
1999, despite recurring reports of their neurotoxicity and carcinogenic impacts (Kümmerer, 
2007).  
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Kümmerer (2007) classifies approaches to manage environmental chemical stressors in 
three broad categories (see Figure 6). The first category, called ―Technical approach‖ is a short 
to medium-term management strategy that works by treating emissions or effluents, also referred 
to as ―end of the pipe technology.‖ The strategy is effective for managing short and concentrated 
emanations as it focuses on major upstream pathways of contamination introduction, but it 
requires the presence of relevant infrastructure. It also fails for trace quantities of pollutants, 
downstream pathways and non-point sources. Industrial treatment of effluents and wastewater 
treatment are some examples of the technical approach.   
 
Figure 6: Approaches to manage pharmaceutical pollution (Kümmerer, 2007) 
The second management strategy, ―Education and training‖, aims to address the issue by 
training the stakeholders about risks of pharmaceutical pollution and how to alleviate them. 
These stakeholders include medical practitioners, hospital staff, pharmacists, and the patients or 
other end users. The strategy includes drug take-back programs, modification of prescription 
doses, containment at source, responsible use and care, and managing illicit drugs. Drug take-
back programs are operational in many countries including most countries in the European 
Union, New Zealand, and Canada, wherein people can deposit unused or leftover medication to a 
pharmacy, hospital or collection center. Such practices are aimed at reducing improper drug 
disposal such as flushing or throwing in trash by the consumer (Kümmerer, 2010, Chapter 11). 
Several ideas have been put forward that explore environmental stewardship by reconsidering 
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current practices of pharmaceutical prescription. Daughton and Ruhoy (2013) recommend 
selecting ―the lowest effective dose‖ of medication possible, to prevent drug overuse and 
wastage. They also recommend personalized dosage according to the needs of each individual 
patient to avoid over-prescription of drugs, and leftover medication due to patient non-
compliance.  The use of Precautionary Principle or PP, as recommended by European 
Commission to regulate risk from chemicals including pharmaceuticals can also supplement this 
management category. Rogers (2003, p. 374) defines PP in two ways: weak PP, which posits that 
―lack of full certainty is not a justification for preventing an action that might be harmful‖; and 
strong PP, which advices to ―take no action unless you are certain that it will do no harm.‖ This 
evidence-based policy intervention, as currently used to regulate hazardous chemicals in Europe, 
is open to interpretation. The burden to provide evidence regarding risks possessed by a 
pharmaceutical rests with the primary producer or manufacturer of the pharmaceutical, while the 
burden to interpret evidence rests on the regulatory body (Larsen, 2004; Rogers, 2003). Recently, 
the precautionary principle has been applied to justify withdrawal of several pharmaceutical 
drugs in EU and worldwide (Onakpoya, Heneghan & Aronson, 2016), but the risks cited to 
justify these withdrawals were regarding human health, including drug-attributed deaths. The 
withdrawal justifications did not include either direct risks to the environment, or impacts on 
human health due to environmental damage. Rogers (2003) also observed that the successful 
application of PP depends upon educating both evidence-providers and regulators on quantitative 
assessment of health and ecological hazards from pharmaceuticals. In the future, more stringent 
use of the precautionary principle can be expected to eliminate the potential environmental risks 
from new pharmaceutical drugs and chemicals by conducting extensive risk assessments and 
environmental or health impact reviews, provided that the social benefits of pharmaceuticals do 
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not outweigh environmental considerations (Larsen, 2004). In sum, while the second strategy is 
more comprehensive in preventing the entry of pharmaceuticals in the environment, it does not 
account for all pathways, and needs to be widely accepted to be effective. The adoption of 
practices mentioned above are also not popular, especially in developing countries. Importantly, 
the second management strategy does not address the source of contamination – the 
pharmaceutical compound itself (Kümmerer, 2004; Kümmerer 2007; Daughton 2003).  
The third strategy advocates the redesign of pharmaceuticals as environmentally-benign 
compounds. A long-term strategy, it calls for the eventual substitution of all potentially toxic 
pharmaceuticals with environmentally-friendly alternatives. It is noteworthy that some policies 
and strategies address only upstream pathways, while some address only downstream pathways. 
When adopted widely, efficient or eco-friendly drugs would reduce or eliminate the need for 
stringent waste disposal, saving time, money, and physical resources. Their use would also 
alleviate the harm that is caused by informal or non-point source of pharmaceutical 
contamination like household excretion and washing (Ruhoy and Daughton, 2008). There are 
very few strategies that comprehensively deal with both pathways while focusing on the cause of 
pollution itself, among which, the best and often the most cited is the green chemistry approach.  
Environmentally-friendly pharmaceuticals  
The idea of using green chemistry to develop environmentally-benign pharmaceuticals 
was first proposed in the field of chemistry around 2000 (Anastas and Warner 1998, Clark and 
Smith 2005, Clark 2006) as a method to address issues and concerns stemming from the presence 
of pharmaceuticals in the environment. Green pharmaceuticals, or benign-by-design drugs are 
pharmaceuticals that, by the virtue of their chemical make-up, either have an efficient 
manufacturing process, are target-specific, have harmless residues, or are bio-degradable 
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(Cordell, 2009; Daughton, 2003; Kümmerer, 2010). In this approach, the full life cycle of a 
pharmaceutical is carefully studied, from its inception to large scale manufacturing, treatment 
capability, and its behavior or fate after being emitted into the environment (Kümmerer, 2010).  
This holistic approach of studying raw materials used, synthesis, manufacturing, use and after-
use life of a drug is also known as ―cradle-to-cradle stewardship‖ (Daughton, 2003; Kümmerer, 
2010). Cradle-to-cradle stewardship as a design and manufacturing approach has been used in a 
wide variety of disciplines ranging from manufacturing and product design to urban planning 
(McDonough & Braungart, 2010), aiming at regeneration of the environment rather than 
reduction of environmental degradation.  Recent literature uses a variety of phrases to discuss the 
field of green chemistry, some among them being ―sustainable pharmacy‖, ―benign-by-nature‖, 
―ecopharmacostewardship‖, and ―sustainable health products‖ (Kümmerer, 2010). Countries like 
the United States (the U.S. Presidential Green Chemistry Challenge Award instituted in 1995), 
Japan, Italy, the UK, and Australia have adopted green chemistry awards to encourage industry 
and academic action in the field (Anastas and Kirchhoff, 2002). 
Taylor (2010) specifies pharmacological objectives that, when achieved, would result in 
sustainable improvements in drug design. These objectives consist of complete oral absorption of 
drug to alleviate emission from patients, drug metabolization that would result in inert residues, 
effective drugs to reduce overall drug use, target-specific or disease receptor specific drugs that 
do not impact healthy receptors, and elimination of side or non-therapeutic effects of a drug (p. 
110). An overhaul of industrial manufacturing and R&D is also leading to more 
environmentally-friendly pharmaceuticals in the market. Many drug synthesis processes have 
undergone major improvements in efficiency, and big pharmaceutical manufacturers are 
collaborating to further these sustainable synthesis routes (Crow, 2008). Biopharmaceuticals, or 
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biologically derived pharmaceuticals, are gaining momentum against synthetically synthesized 
chemicals – leading to a much less toxic manufacturing chain. Industries are shifting to less toxic 
solvents for bulk drug manufacturing than conventional solvents (Taylor, 2010). Pharmaceutical 
manufacturing companies are also rethinking the basic composition of drug molecules, 
redesigning to avoid certain non-biodegradable chemical bonds like the carbon-fluorine bond 
(Lubick, 2008).  
Despite the widely accepted and endorsed benefits of green chemistry, the approach still 
faces some critical challenges. By extension, these challenges also apply to the adoption of 
environmentally-friendly pharmaceuticals. Anastas and Kirchhoff (2002) classify these 
challenges into three groups: research challenges, implementation challenges, and education 
challenges. Research challenges include development of solvents, methodologies, processes, 
surfaces, materials, and energy sources that do not cause harm to humans and the environment. 
Implementation challenges involve overcoming the barriers of codes and regulations, provision 
of tax incentives and long-term research programs, and patent extensions for process 
optimization. Education challenges include the systemic recognition of green chemistry, 
updating textbooks, labs, and coursework to include green chemistry, and educating legislators 
and all stakeholders involved (Anastas & Kirchhoff, 2002, p. 691).   
Green chemistry in India is still in the nascent stage. The country saw the establishment 
of a chapter of Green Chemistry Institute in New Delhi in 2003 and sanctioned the proposal for 
establishment of a Center for Green Technology in 2004 (Yadav, 2006). Ecopharmacology is 
also recognized as an emerging field in India. Gupta and Mahajan (2015) compiled a series of 
manufacturing processes optimized to reduced environmental damage, consisting of 
manufacturing for various solvents and synthetic chemicals used in production of 
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pharmaceuticals. In the pharmaceutical industry, sustainable methodologies are available for the 
production of various antibiotics and different drugs used to lower cholesterol, control diabetes, 
control central nervous system disorders, regulate cardiovascular system, treat depression, and 
complement anti-cancer treatment or chemotherapy (Gupta & Mahajan, 2005).  The Bureau of 
Indian Standards, in 2006, adopted industry standards and guidelines for chemicals and 
pharmaceuticals with respect to their environmental life-cycle assessment (IS/ISO 14040:2006), 
but the country has not seen extensive reporting on sustainability in the pharmaceutical industry. 
By 2013, only 2 of the 9 Big Pharma companies in India had released reports of their 
sustainability initiatives (Chaturvedi, Sharma, Dangayach & Sarkar, 2017).    
Green manufacturing and supply chain in India 
The challenges to widespread adoption of environmentally-friendly pharmaceuticals 
include demand from consumers, so it is discussed in the following text how consumer support 
can result in incentives for adoption of this long-term sustainable strategy against pharmaceutical 
pollution.  Finally, the theoretical framework and rationale behind this research study are 
reported, along with research questions and hypotheses examined in the study. 
As the sustainable pharmaceutical industry in India is in its initial stages, the studies 
about advanced green manufacturing and supply chains in more established industries can 
provide useful knowledge applicable to the pharmaceutical industry. Several studies have 
explored motivations for large manufacturers and traders to engage in environmentally-friendly 
supply chains and manufacturing across prominent industries like auto components, cold storage 
and refrigeration, electricals and electronic manufacturing, mining, and construction. Principal 
among these are studies on Indian industries and markets done by Bag (2016), Mathiyazhagan & 
Haq (2013), and Muduli, Govindand, Barve & Geng (2013). The studies found that the most 
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important factors that incentivizing large companies to engage in green practices include 
government regulations, local laws, tax incentives, and land subsidies. In addition, 
Mathiyazhagan & Haq (2013) find that a significant motivating factor in India is the demand 
from the consumers and stakeholders, especially for large companies and suppliers, as it creates a 
bottom-up pressure. Sustained profit margins and long-term feasibility, along with image of the 
company through Corporate Social Responsibility (CSR), are also crucial significant factors for 
promoting eco-friendly manufacturing and supply (p. 830).  
Rationale for the thesis 
One of the crucial challenges to adoption of environmentally-friendly pharmaceuticals, 
according to the literature discussed above, are educational challenges that include substantiating 
stakeholder awareness and involvement, and demand from consumers, especially in India. It is 
therefore imperative to study existing consumer perceptions to establish point of actions and best 
strategies to encourage change in behavior and consumer action.  In recent past, a growing 
number of campaigns have successfully effected change in consumer behavior by focusing on 
education about environmental problems and environmentally-friendly alternatives. Even 
international policymakers have invested in social marketing campaigns to promote pro-
environmental consumer behavior, often accompanied by financial incentives to the industries to 
gain leverage (European Commission, 2008; Kollmuss & Agyeman, 2002; Whitmarsh & 
O‘Neill, 2010).  
 A close review of literature reveals that certain specific factors influence public 
perception and individual behavior regarding environmental pollution. Individual behavior that 
positively affects the environment is often called ecological behavior or environmentally-friendly 
behavior in these texts. Studies have expounded on certain measurable qualities or traits of an 
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individual that cumulatively determine the likelihood of an individual to engage in ecological 
behavior. Various types of ecological behaviors have been studied in diverse settings, including 
shopping for organic food, willingness to purchase renewable energy, disposal of medication, 
etc. in countries from the European Union and the US, UK, Canada, New Zealand, China, Japan, 
Singapore, and Kuwait (Bang, Ellinger, Hadjimarcou & Traichal, 2000; Götz & Keil, 2007; 
Grunert 1993).  Most of these studies focus on individual behavior at the level of consumer, and 
not holistically on the entire life cycle or supply chain.  
In the field of pharmaceuticals in the environment (PiE), well-known studies about 
consumer behavior are those regarding popularity of and compliance with drug take-back 
programs (Abahussain & Ball, 2007; Daughton, 2003, Götz & Keil, 2007). To the best of the 
author‘s knowledge, no study has analyzed consumer perceptions regarding pharmaceutical 
pollution, especially in the Indian context. This research thesis thus fills a crucial gap in the field 
by analyzing perceptions of consumers towards environmentally-friendly pharmaceuticals in a 
country that is facing severe environmental degradation due to active chemical drugs.  It is 
expected that this research would provide a nuanced understanding of consumer perceptions in 
India, which could then encourage manufacturers to invest in, and market eco-friendly 
pharmaceuticals. It will also help to raise awareness about the issue of pharmaceutical 
contamination and identify areas of intervention for public policy campaigners, especially for 
imminent India-specific issues like industrial effluent discharge, and antimicrobial resistance. 
Theoretical framework 
In the field of environmental psychology, most discussions around environmental 
attitudes and ecological behavior are grounded in the theory of reasoned action (Ajzen & 
Fishbein, 1980) and the theory of planned behavior (Ajzen, 1985). The theory of reasoned action 
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by Ajzen & Fishbein (1980) posits that a particular behavior is immediately preceded by an 
intention to perform that particular behavior. In most studies that have measured ‗ecological 
behavior intention‘ and ‗ecological behavior‘, the two variables are strongly, or at least 
moderately correlated (Kaiser, Wolfing & Fuhrer, 1999), however, the strength of this 
correlation varies greatly across the behaviors studied. Some ecological behaviors are strongly 
associated with environmental attitudes, environmental knowledge, environmental values, or 
ecological behavioral intention, while others are not; specific ecological behaviors such as 
recycling or use of public transport, are more strongly associated with environmental attitudes, 
while general behaviors such as taking care of the environment or participating in environmental 
activities, are moderately associated (Kaiser et al., 1999).   
 
Figure 7: Theory of reasoned action - intention precedes behavior (Ajzen & Fishbein, 1980) 
Kaiser and colleagues (1999) also suggest three concepts as the skeleton of the theory of 
planned behavior: environmental knowledge, environmental values, and ecological behavioral 
intention. In addition, these authors state that the relationship between general attitudes and 
general behavior should remain consistent regardless of ideological differences among people. 
Environmental knowledge encompasses factual knowledge about the environment, and the 
knowledge about what and how something can be done. Environmental values are social and 
moral values regarding the environment. Ecological behavior includes actions that contribute to 
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environmental preservation or conservation. Ecological behavior intention immediately precedes 
ecological behavior and is a function of the environmental attitude towards performing an act 
and subjective norms or the expectations of others (Kaiser et al., 1999). 
Research variables 
By applying the theory of reasoned action (Ajzen and Fishbein, 1980) and its 
interpretation for studying environmentally-friendly behavior (Kaiser et el., 1999) to this 
research study, it becomes evident that consumer perceptions toward pharmaceutical in the 
environment can be examined through the study of environmental knowledge, values, and 
intention. Environmental knowledge can be interpreted in the context of this study as knowledge 
of the issue of pharmaceutical pollution, and the risks associated with it.  Environmental values 
can be interpreted as environmental concern. The study of ecological behavior takes more time 
and resources than available for this research; thus, ecological behavior intention is studied. 
While ecological behavior intention is not a true indicator of ecological behavior, the two are 
expected to be associated according to the theory of planned behavior and theory of reasoned 
action (Ajzen & Fishbein, 1980; Ajzen, 1985), with intention being the immediate predecessor of 
the behavior or action.  Details about each measurable variable are discussed in the following 
paragraphs. All variables measured for the purpose of this study are presented in Figure 8. 
23 
 
 
Figure 8: Research Design 
Environmental concern: Yeung (2004) defines environmental concern as ―an affective 
attribute that can represent a person‘s worries, likes and dislikes about the environment‖ (Yeung, 
2004, p. 101). Similar to a person‘s attitude towards the environment, it can cover either general 
or some particular aspects of the environment (Kaiser et el., 1999) and encompasses people‘s 
tendencies to live and act in an environmentally responsible way (Yeung, 2004). Environmental 
concern has been used to study pro-environmental behavior. For example, Mobley, Vagias, and 
DeWard (2010) measured environmental concern in their study to predict environmentally-
responsible behavior in US residents.  Lee (2008, 2014) used the attribute to predict sustainable 
consumption among young people in Hong Kong, and Yeung (2004) used it to evaluate the 
effect of teaching approaches on students‘ environmental attitudes. In this research study, 
environmental concern is measured to understand the extent of a consumer‘s interest in issues 
related to environment.  
Self-estimated or Subjective Knowledge: According to Vandermoere (2008), subjective 
or self-estimated knowledge refers to an individual‘s perception about their personal knowledge 
of a specific issue. The measure is used in risk perception studies to examine the ―familiarity 
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effect‖ (Slovic, 1987), which states that the level of familiarity with a particular risk may affect 
people‘s perceptions of it. Both objective and subjective knowledge contribute to people‘s 
opinions. Self-estimated knowledge has been measured in studies that examine perceptions of 
residents exposed to soil pollution (Vandermoere, 2008), and perceptions regarding genetically 
modified foods (Durant & Legge, 2005). In this study, self-estimated knowledge is measured to 
get a nuanced understanding of consumers‘ perceptions about the issue of pharmaceutical 
pollution.  
Risk Perception: The field of risk analysis uses risk perception measures to study 
people‘s opinions about a particular threat. Risk perception involves various attributes like 
newness or familiarity of risk, severity of consequences, and social trust (Slovik, 1987). 
Perception of risk is also related to the acceptance of a new concept by the public, like gene 
technology (Sparks, Shepherd & Frewer, 1994) and e-commerce (Pavlou, 2003). In the study, 
risk perception is used to determine the acceptance of the risk from existing pharmaceutical 
pollution among Indian citizens. 
 Consumer Intention: The inclination of a consumer to engage in a particular behavior is 
called consumer intention. Consumer intention is also used to predict pro-environmental 
behavior or stewardship by a consumer (Hensen, Keeling, Ruyter & Wetzel, 2016). The concept 
of consumer intention has been used to study marketing effects on pro-environmental behavior 
(Kollmuss & Agyeman, 2002; Whitmarsh & O‘Neill, 2010) and environmentally-friendly 
alternatives to conventional products (Steg & Vlek, 2009). A comprehensive term for long-term 
environmentally-friendly consumer intention, consumer stewardship is defined (Hensen et al., 
2016, p. 390) as ―an individual‘s willingness to take personal responsibility for, and balance 
one‘s own short-term interests with long-term collective interests of the environment, society and 
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future generations, even if this requires personal sacrifices in consumption decision.‖ In this 
study, environmentally-friendly consumer intention is used to ascertain the willingness of Indian 
consumers to buy green pharmaceuticals, since studies indicate that intention directly leads to 
action (Kaiser et al., 1999).  
Research Questions and Hypotheses 
The following research questions will be explored through this thesis.   
Research Question 1(a): What are the levels of environmental concern, awareness about 
pharmaceutical pollution, perceived risk of pharmaceutical pollution, and environmentally-
friendly consumer intention among Indian consumers? (b) Do the levels of environmental 
concern, awareness about pharmaceutical pollution, perceived risk, and consumer intention vary 
with age, education level, or gender (see Figure 9)?  
 
Figure 9: Research Question 1(b) 
The levels of environmental concern, awareness about pharmaceutical pollution, 
perceived risk of pharmaceutical pollution, and environmentally-friendly consumer intention 
among Indian consumers will be assessed.   It is hypothesized that citizens do not have much 
information about the subject of pharmaceutical pollution, nor consider it an important 
environmental threat. On average, younger people (ages 44 years and younger), and citizens with 
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higher education levels (bachelor‘s degree/diploma and above) are expected to have higher levels 
of environmental concern, awareness about pharmaceutical pollution, perceived risk, and 
environmentally-friendly consumer intention than older citizens and citizens with lower levels of 
education.  
Research Question 2 (a): Are environmental concern, awareness about pharmaceutical 
pollution, and perceived risk each individually associated with the dependent variable, 
environmentally-friendly consumer intention (see Figure 10)? (b) Do age, education and/or 
gender moderate the associations between the independent variables (environmental concern, 
self-estimated knowledge, risk perception) and the dependent variable (consumer intention) (see 
Figure 11)? 
 
Figure 10: Research Question 2(a) 
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Figure 11: Research Question 2(b) 
The independent variables, environmental concern and awareness about pharmaceutical 
pollution, are expected to be positively correlated with scores on Consumer Environmental 
Stewardship (CENS) scale.  Risk perception is also expected to be positively associated with 
consumer intention. Second, on average, younger citizens (ages 44 years and younger), and 
citizens with higher education levels (bachelor‘s degree/diploma and above) are expected to have 
higher consumer intention scores than older citizens and citizens with lower levels of education. 
Third, the associations of each independent variable with the dependent variable are expected to 
be moderated by demographics of age and/or education level. Specifically, it is hypothesized that 
the positive effect of each independent variable on consumer intention will be stronger for 
younger citizens (ages 44 years and younger), and for citizens with higher education levels 
(bachelor‘s degree/diploma and above) than for older or less educated participants. 
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Research Question 3: Which among the three independent variables — environmental 
concern, awareness, and perceived risk — are the most salient correlates of environment-friendly 
consumer intention (see Figure 12)?  
 
Figure 12: Research Question 3 
It is hypothesized that environmental concern will be most strongly correlated with 
environment-friendly consumer intention.  Most studies that have evaluated the relation between 
environmental concern and pro-environmental behavior or consumer intention find a strong or 
moderate correlation between environmental concern and behavior/intention (Kaiser, 1999; Lee, 
2014; Mobley, Vagias, & DeWard, 2010). This study is expected to be consistent with the results 
that environmental concern is the strongest predictor of consumer intention after controlling for 
age, gender, and education level.   
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CHAPTER 2 
METHOD 
Research Design 
This non-experimental research study (one group post-test only, or case study) is aimed at 
understanding adult Indian consumers‘ perceptions regarding medication and the environmental 
contamination resulting from pharmaceutical pollution. The purpose of this study was to evaluate 
the level of environmental concern among the population. The study tested whether people 
showing high levels of environmental concern and perceived risk from pollution also showed 
stronger intention to engage in environment-friendly consumer practices. Quantitative data were 
collected in the field using survey questionnaire from people visiting a pharmacy in Indore, 
India.  
Site Selection and Description 
Indore is situated in the state of Madhya Pradesh in India. The city is an important 
business hub for central India and over 76 pharmaceutical companies have a management or 
regional office located in the city. Pithampur, one of the biggest industrial areas of Asia, is 
located about 30 km (18.6 miles) from Indore. Pithampur is home to at least 16 different drug 
manufacturing units, which provide pharmaceuticals and active pharmaceutical ingredients for 
supply throughout central and western India.  
Indore has recently seen a surge in awareness against pollution due to municipal 
initiatives promoting ideas like ―Clean Indore, Green Indore‖. Indore has also been voted as the 
cleanest city in India for two consecutive years, according to the annual citizen‘s poll conducted 
by the Swachh Bharat Campaign (Annual Report, 2017, Swachh Bharat Abhiyan).  
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The site selected for this study was a pharmacy, New Look Optics and Pharmacy, situated 
on the premises of Rohit Eye Hospital, Indore. The setting for data collection was chosen to be a 
pharmacy as people visiting a pharmacy are likely to consume medication and often are faced 
with choices regarding consumer decisions.  New Look Optics and Pharmacy is in geographic 
proximity to neighborhoods of varying income levels to maximize demographic variation.   
Participants  
A semi-random sampling procedure was used for this study. Adults visiting the pharmacy 
were first asked orally if they have a few minutes to take a survey, and then asked for their 
consent. All adults in the age range of 18 to 85 years visiting the research site were asked to 
participate in the study. The sample was expected to be representative of the population living in 
Indore, as the pharmacy is visited by people from diverse social and economic backgrounds.  
As shown in Table 1, the most common age group represented in the study was 18 to 24 
years, with 24% of respondent belonging to this category. Forty-seven percent of the respondents 
were male, and 53% female. The most represented education level was Secondary (Grade 6 to 
10), with 23% of the participants belonging to this category.  
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Table 1 
 
Demographic information of participants 
Demographic Variable  Number Percentage (%) 
Gender 
  Male 65 47% 
Female 72 53% 
Age 
  18-24 33 24% 
25-34 23 17% 
35-44 30 22% 
45-54 26 19% 
55-64 16 12% 
65-74 8 6% 
75-84 1 1% 
>85 0 0% 
Education Level 
  No schooling 15 11% 
Primary (Grade 1 to 5) 10 7% 
Secondary (Grade 6-10) 31 23% 
Post-secondary (Grade 11-12) 23 17% 
Tertiary (Bachelor's degree or diploma) 30 22% 
Post-graduate (Master's or above) 25 19% 
 
Demographic information of the participants of this study was compared to the 
demographics of the city of Indore, and of India. As shown in Table 2, the sample demographics 
were comparable with those of the population of the city and the country, especially according to 
age groups and gender. 
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Table 2 
 
Comparison of demographic information  
Demographic Variable  Study (2018) Indore (Urban) India 
Age 
   18-24 24% 10% 19% 
25-34 17% 18% 15% 
35-44 22% 14% 13% 
45-54 19% 10% 9% 
55-64 12% 6% 6% 
65-74 6% 3% 4% 
>75 1% 2% 2% 
  
  Gender 
   Male 47% 52% 51% 
Female 53% 48% 49% 
    Literacy Rate  N/A 85% 73% 
Note. Data Source: Census of India, 2011 
 
Data collection procedure 
Data were collected from February 22 to March 9, 2018. A total of 141 responses were 
collected in this period. Participants were told that the research assistant would like to ask a few 
questions regarding medicines and environmental pollution. Upon obtaining consent, participants 
were asked to take a 15-minute survey. A research assistant administered the survey in the local 
language at the pharmacy counter by reading the questions aloud, to which the participant either 
responded orally or indicated their response on a printed scale scorecard. Each survey response 
took about 10 minutes, and participants were compensated with eye checkup coupons worth INR 
300 ($4.60) for their participation.  
The entire data collection process was conducted in the local language, Hindi, to ensure 
comfort of all participants and maintain language uniformity. The survey was translated in Hindi 
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and the original survey was compared with a back-translated English version to check meaning 
loss in translation (see Appendix A for English and Hindi versions of the questionnaire). The 
study was granted exemption from review by the Cornell University Institutional Review Board 
(see Appendix B).    
Constructs and Measures 
The study included four independent variables (consumption of pharmaceuticals, 
environmental concern, awareness about pharmaceutical pollution, and perceived risk of 
pharmaceutical pollution) and one dependent variable (environment-friendly consumer 
intention), in addition to recording demographic information about each participant. All 
measures were self-reported on a Likert or Likert-type scale and have been provided in Appendix 
A for reference. Likert scales are interval scales that provide 1-5 or 1-7 response options related 
to agreement and disagreement with a series of statements.  
1. Consumption of Pharmaceuticals was measured to recognize the most commonly 
consumed over-the-counter (OTC) pharmaceutical drugs by the surveyed population. The 11-
item scale from Sihvo, Klaukka, Martikainen, & Hemminki (2000) categorized non-prescription 
drugs into 10 categories according to the 1993 Anatomic-Therapeutic Classification (ATC). The 
measure was modified to include common Indian name brands of drugs as examples for each 
category of medication. The measure was introduced by the research assistant with the following 
instruction: ―Please tell me what medicines you have consumed during the last two days. Do you 
consume these medicines daily or weekly (used regularly), or do you use them occasionally (as 
needed)?‖ Participants were asked to indicate categories of medicines consumed in two days 
preceding the survey (Vitamins/Mineral Supplements, NSAIDs, Analgesics, Antibiotic, 
Antianemia Preparations, Antacids, Antihistamines, Cough and Cold Preparations, Topical 
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Products for Muscular Pain, Laxatives or alternatively, none). They were also asked to indicate if 
they consumed the pharmaceuticals as and when required (Used Occasionally), or if they 
consumed them daily or weekly (Used Regularly).  
2. Environmental Concern was measured using the Environmental Concern Scale (Lee, 
2014) adapted to reflect Indian context.
1
 The original scale was developed to examine 
sustainable consumption among the young educated population of Hong Kong. The original 13-
item scale had strong internal consistency with a Cronbach Alpha value of α = 0.94. One item 
was removed due to possible translation error in the original measure.
1
 The modified scale 
consisted of 12 items measured on a 7-point Likert Scale ranging from ‗strongly disagree‘ to 
‗strongly agree‘ and included statements like ―I am worried about the worsening of the quality of 
India‘s environment‖, and ―I think it is very important to advocate environmental protection to 
Indian citizens.‖ The modified scale for this study had a high Cronbach Alpha value (α = 0.94).   
3. Awareness about Pharmaceutical Pollution was measured with a self-reported 
Subjective/Self-estimated Knowledge Scale modified from Vandermoere (2008). The scale 
consisted of 4 items measured on a 5-point scale ranging from ‗not at all‘ to ‗very much‘, and 
―less informed‖ to ―better informed.‖ The original scale was developed to assess subjective 
knowledge of Belgian people about chemical contamination of their residential land parcels due 
to former industrial activities. It was adapted to the context of the current study.
2
 The scale 
included questions such as: ―To what extent do you feel informed about the problem of 
                                                 
1
 In all items, ‗Hong Kong‘ was replaced by ‗India‘. For example, ―I am worried about the worsening of the quality 
of Hong Kong‘s environment.‖ was changed to ―I am worried about the worsening of the quality of India‘s 
environment.‖ The item ―I often think about how the pollution problem in Hong Kong‖ was the 12th item in the 
original measure but was removed from the modified measure.   
2
 All four items on the original scale were modified to reflect the context of current study. For example, ―To what 
extent do you feel informed about the previous industrial activities on the site?‖ was replaced by ―To what extent do 
you feel informed about the problem of pharmaceutical pollution in India?‖ 
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pharmaceutical pollution?‖ and ―To what extent do you feel informed about the pharmaceutical 
pollution in India in comparison with other residents?‖ The 4-item scale was reported to have 
moderate internal consistency (α = 0.797) (Vandermoere, 2008), and face validity was 
established by consultation with experts. Cronbach Alpha for the scale was found to be high (α = 
0.92) for the current sample.   
4. Perceived Risk of Pharmaceutical Pollution was measured with a Risk Perception 
Measure modified from Huang et al. (2013), developed to assess risk acceptance of chemical 
industry in Jiangsu Province, China.  The measure was adapted to the context of the current 
study by changing ―chemical‖ pollution to ―pharmaceutical‖ pollution for all items, one item was 
further modified to clarify the context, and the number of items were reduced from 9 to 8 to omit 
an item which was not relevant to the study
3
. The modified measure consisted of 8 items, each 
measured on 5-point scales. It included questions like ―Will the effects of the risk of 
pharmaceutical pollution occur immediately, or will they take place in the future?‖ measured on 
a 5-point scale ranging from ‗will occur immediately‘ to ‗will occur far in the future‘. The scale 
was found to have a high Cronbach Alpha (α = 0.83) for the current study.  
5. Environment-Friendly Consumer Intention or the intention of a person to engage in 
sustainable consumer behavior was measured using the Consumer Environmental Stewardship 
(CENS), developed by Hensen, Keeling, Ruyter, & Wetzels (2016) to examine individual 
responsibility towards the environment (p. 390). Construct validity of the scale was assessed 
using confirmatory factor analysis, which was supported by demonstration of both convergent 
                                                 
3
 The original item of ―How many people are subjected to the risk of chemical pollution?‖ was modified to ―How 
many people are subjected to the risk of pharmaceutical pollution throughout all of India?‖ The item, ―How 
acceptable is the risk of chemical industries to which you are subjected?‖ was removed as it was not relevant to the 
study. 
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and discriminant validity with previously established scales. The scale was adapted to the Indian 
context by making minor changes to the language. It consisted of 10 items measured on 7-point 
Likert scale ranging from ‗strongly disagree‘ to ‗strongly agree‘. This measure included 
questions such as ―I feel a personal sense of responsibility for the environment,‖ and ―In my 
service to society I should balance short-term personal goals with long-term environmental 
goals‖. The measure was found to have high Cronbach Alpha in both the source of the measure 
(α = 0.93) (Hensen et al., 2016) and for the current sample (α = 0.91).  
Analytic Plan 
All paper survey responses were input using Qualtrics, the online survey software, to get 
data in digital form. The statistical software Minitab 17 was used to perform all statistical tests.  
For all statistical tests, the confidence interval used as significance threshold was 95% (p < 0.05, 
two-sided confidence intervals, Adjusted or Type III sum of squares).  The aggregate score for 
each variable was obtained using weighted averages of the items on the scale. The weight for 
each item was calculated using unrotated factor loadings from Confirmatory Factor Analysis for 
each variable. The aggregate scores thus acquired were used for all subsequent statistical 
analyses. 
Research Question 1) For Part (a), descriptive statistics were calculated and reported to 
ascertain levels of environmental concern, awareness about pharmaceutical pollution, perceived 
risk of pharmaceutical pollution, and environmentally-friendly consumer intention among Indian 
consumers (see RQ 1 (a)).  The central tendencies thus obtained were used to evaluate the first 
set of hypotheses for this research question. For part (b), to examine age, education, and gender 
differences in environmental concern, awareness about pharmaceutical pollution, perceived risk, 
and consumer intention (see RQ 1 (b)), each demographic variable was dichotomized (Gender: 
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Male/Female; Age: Young/Old; Education Level: High/Low). Group-wise descriptive statistics 
were calculated, and significant differences were observed using ANOVA. Analysis of Variance 
or ANOVA
4
 is a statistical technique used to test whether there is a difference between the 
means of several samples. The significance of difference in mean score values was assessed 
using Tukey‘s pairwise comparison, which compares all possible pairs of means and is used for 
unequal sample sizes.  
Research Question 2) For part (a) of this research question, general linear models were 
used to examine the main effect of each independent variable individually with the dependent 
variable, consumer intention (see RQ 2 (a)). General Linear Model
Error! Bookmark not defined.
 is an 
extension of regression and correlational analysis and is commonly used in social science 
research where there is one dependent variable, and the independent variables are either 
categorical or covariates. For part (b) of the question, to analyze moderator/interaction effects of 
demographics on each IV-DV relation (see RQ 2 (b)), general linear models with stepwise 
backward elimination were used. Each association of independent variable with the dependent 
variable, i.e. environmental concern with consumer intentions; self-estimated knowledge with 
consumer intention; and risk perception with consumer intention, were analyzed for interaction 
effects of age, education level, and gender. All demographics were input in the models, and 
significant interactions were obtained through stepwise backward elimination. The significance 
level used for elimination of terms was α = 0.05.   
Research Question 3) A general linear model with standardized regression coefficients 
was tested with all three independent variables as covariates and consumer intention as the 
                                                 
4
 As explained by Françoise Vermeylen, Director and Statistician at Cornell Statistical Consulting Unit. 
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dependent variable, to analyze the cumulative associations among the variables (see RQ 3). The 
independent variable having the greatest effect on consumer intention score would be the one 
with the highest value of the standardized coefficient (SE β) in the model. For this analysis, 
continuous predictors of environmental concern, self-estimated knowledge, and risk perception 
were standardized by subtraction of the mean followed by division by standard deviation.   
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CHAPTER 3 
RESULTS 
Results obtained from statistical analyses of survey data are presented here, organized 
according to the research questions of this study.  Before presenting the findings with respect to 
each of the three research questions, the weighted averages used to obtain aggregate scores for 
all variables are reported in Table 3, and information about consumption of pharmaceuticals is 
reported in Table 4. To examine RQ 1, descriptive statistics for the aggregate scores of the 
sample population on environmental concern, self-estimated knowledge, perceived risk, and 
consumer intention are presented. Next, to examine RQ 2, statistical models showing the 
associations of each independent variable (environmental concern, self-estimated knowledge, 
and risk perception) with the dependent variable (consumer intention) are reported, followed by 
examination of interaction effects of demographic variables (age, education level, and gender). 
Finally, to examine RQ 3, a model showing the cumulative relationship of all three independent 
variables with the dependent variable is reported.  
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Table 3 
 
Item-wise factor loadings used to calculate aggregate scores for each variable  
Questions Scale Factor Loading 
Environmental Concern, α = 0.94 
  
 
I am worried about the worsening of the quality of India's environment. 1 to 7  0.85 
 
I am worried that our pollution problem is getting worse. 1 to 7  0.70 
 
I cherish our earth very much. 1 to 7  0.82 
 
I fully support environmental protection. 1 to 7  0.90 
 
It's very important to advocate green living in India. 1 to 7  0.88 
 
Environmental protection is one of my major concerns. 1 to 7  0.85 
 
I fully support to have more environmental activities organized in India. 1 to 7  0.89 
 
I regard myself having a responsibility to protect the environment. 1 to 7  0.87 
 
I am emotionally involved in environmental protection issues in India. 1 to 7  0.85 
 
I think about how the environmental quality in India can be improved. 1 to 7  0.76 
 
I think it is very important to advocate environmental protection to Indian citizens. 1 to 7  0.91 
 
I totally agree with the statement that ―environmental protection starts with me.‖ 1 to 7  0.84 
    Self-Estimated Knowledge, α = 0.92 
  
 
To what extent do you feel informed about the problem of pharmaceutical pollution? 1 to 5 0.89 
 
To what extent do you feel informed about the problem compared with other residents? 1 to 5 0.88 
 
To what extent do you feel informed about pharmaceutical pollution in India? 1 to 5 0.92 
 
To what extent do you feel informed about the pharmaceutical pollution in India 
compared with other residents? 
1 to 5 0.91 
    Risk Perception, α = 0.83 
  
 
Is the risk of pharmaceutical pollution new and unfamiliar, or is it old and familiar? 1 to 5 0.59 
 
How much knowledge do you have of the risk of pharmaceutical pollution? 1 to 5 0.67 
 
How beneficial to local economic development is the pharmaceutical industry? 1 to 5 0.6 
 
Will the effects of the risk of pharmaceutical pollution occur immediately, or will they 
take place in the future? 
1 to 5 0.55 
 
How many people are subjected to the risk of pharmaceutical pollution throughout all of 
India? 
1 to 5 0.76 
 
When the risk of pharmaceutical pollution appears, how fatal will the consequences be? 1 to 5 0.79 
 
To what degree can the risk be avoided by the exposed population? 1 to 5 0.81 
 
To what degree do you trust in the government or related policy makers' risk 
management abilities? 
1 to 5 0.74 
    Consumer Intentions, α = 0.91 
  
 
I feel a personal sense of responsibility for the environment. 1 to 7  0.82 
 
I feel accountable for the environmental impact of my purchases. 1 to 7  0.81 
 
I think it is inappropriate, for me as a single person, to buy products without considering 
the environmental impact of them. 
1 to 7  0.9 
 
When searching for a product I should seek a balance between its costs and its impact on 
the environment. 
1 to 7  0.92 
 
I am willing to make personal sacrifices for the good of the environment. 1 to 7  0.86 
 
I carry responsibility for the environmental impact of my purchases on society. 1 to 7  0.91 
 
I need to help maintaining a green environment for society. 1 to 7  0.75 
 
In my service to society I should balance short-term personal goals with long-term 
environmental goals. 
1 to 7  0.89 
 
I feel responsible for the environmental impact of my purchases on future generations. 1 to 7  0.92 
  I need to help maintain a green environment for future generations. 1 to 7  0.82 
 
41 
 
Consumption of Pharmaceuticals 
The participants of the study indicated their consumption of over-the-counter 
pharmaceuticals, classified in ten categories (Table 4). The most common occasionally 
consumed medicines were analgesics, with 40% of the surveyed population indicating that they 
had consumed analgesics during the two days preceding the survey. Of medicines that were 
indicated to be used regularly, topical products for muscular pain were most common, their use 
being indicated by 6.5% of the surveyed participants. In total, 71.7% of the respondents indicated 
that they had used some OTC medication in the two days preceding the survey. Only 28.3% of 
the respondents indicated that they had not consumed any pharmaceuticals in the two days 
preceding the survey.        
Table 4 
 Consumption of Pharmaceuticals 
Medicine Used Occasionally Used Regularly 
Vitamins + Mineral Supplements  27% 5.0% 
NSAIDs 32% 0.7% 
Analgesics 40% 0.1% 
Antibiotics 24% 0.2% 
Antianemia Preparations  13% 0.0% 
Antacids 18% 0.2% 
Antihistamines  16% 0.7% 
Cough and Cold Preparations  27% 1.4% 
Topical Products for Muscular Pain  19% 6.5% 
Laxatives  14% 0.7% 
None 
 
28.3% 
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RQ 1(a): What are the levels of environmental concern, self-estimated knowledge, 
perceived risk of pharmaceutical pollution, and environmentally-friendly consumer intention 
among Indian consumers?  
The following text reports the central tendencies and ranges of aggregate scores for all 
variables; environmental concern, awareness about pharmaceutical pollution, perceived risk of 
pharmaceutical pollution, and environmentally-friendly consumer intention. The detailed 
descriptive statistics are reported in Table 5. 
Table 5  
  
Aggregate scores of participants for all variables (n = 137)  
 
Environmental 
Concern  
Self-Estimated 
Knowledge  
Risk 
Perception 
Consumer 
Intention  
Mean (SD) 5.66 (1.23) 2.89 (1.30) 3.44 (0.90) 5.50 (1.25) 
1st Quartile 5.49 1.75 2.86 5.49 
Median 6.00 3.00 3.59 6.00 
3rd Quartile 6.32 4.00 4.11 6.13 
Range  3.19 - 7.00 0.29 - 5.00 1.64 - 4.85 2.99 - 7.00 
 
Environmental Concern: It was hypothesized that the participants would have low- to 
middle-range scores on Environmental Concern, but the results from survey population did not 
support this hypothesis. On average, participants showed high environmental concern (on a scale 
of 1 to 7; 1 = low environmental concern; 7 = high environmental concern), with a mean score of 
5.66 with standard deviation of 1.23. The median score of the surveyed population was 6, which 
indicates that half of the sample population scored 6 or higher on the scale. Only a quarter of the 
sample population had a score lower than 5.49 (first quartile).  
Self-estimated Knowledge: As hypothesized, the participants demonstrated low self-
estimated or subjective knowledge on the topic of pharmaceutical pollution in general and in 
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India. On average, the scores on the scale (scale of 1 to 5; 1 = low self-estimated knowledge, 5 = 
high self-estimated knowledge) were low-range, with mean score of 2.89 and standard deviation 
of 1.30. The median score was 3, indicating that half the surveyed population had self-
estimated/subjective knowledge scores above 3 while the other half had scores below 3.  
Risk Perception: It was hypothesized that the respondents‘ perception of risk from 
pharmaceutical pollution would be low as they are not well-informed about its threats. However, 
the survey results indicate mid-range scores for risk perception. According to the given dataset, 
the mean score on Risk Perception scale (scale of 1 to 5; 1 = low perceived risk; 5= high 
perceived risk) was 3.44 and standard deviation was 0.90. The median score was 3.59, and based 
on the first and third quartile scores, half of the surveyed population had mid-range scores 
between 2.86 and 4.11. 
Consumer Intention: The surveyed population had high-range scores for environment-
friendly consumer intention, with a mean of 5.50 (on a scale of 1 to 7; 1 = low environmental 
concern; 7 = high environmental concern), with a standard deviation of 1.25. The median score 
was 6, implying that half of the people surveyed had a score of 6 or above on the scale. Only a 
quarter (25%) of the respondents had scores less than 5.49.  
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RQ 1(b): Do the levels of environmental concern, awareness about pharmaceutical 
pollution, perceived risk, and consumer intention vary by age, education level, or gender (see 
Figure 13)? 
 
Figure 13: Research Question 1(b) 
The mean levels of environmental concern, self-estimated knowledge, perceived risk, and 
consumer intention vary by age (young-old), education level (high-low), and gender (female-
male). Some of these variations are statistically significant. The following paragraphs report the 
correlations between demographic variables and all variables: environmental concern, self-
estimated knowledge, perceived risk, and consumer intention, as obtained by general linear 
model analysis of each variable with demographic categories (Figure 13). Table 6 reports the 
statistical values obtained from the correlational analyses.  
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Table 6   
   
Correlations between aggregate scores of variables, and demographics  
Variable n M SD F p 
Environmental Concern      
Age    5.90 0.016* 
Young (≤ 44 years) 86 5.87 0.97   
Old (≥ 45 years) 51 5.29 1.52   
Education Level    3.47 0.065 
Low (Grade 12 or lower) 82 5.46 1.30   
High (Bachelor‘s degree/diploma or higher) 55 5.95 1.06   
Gender    0.51 0.475 
Male 65 5.66 1.18   
Female 72 5.66 1.29   
      
Self-Estimated Knowledge      
Age    2.32 0.130 
Young (≤ 44 years) 86 3.06 1.31   
Old (≥ 45 years) 51 2.60 1.24   
Education Level    8.91 0.003* 
Low (Grade 12 or lower) 82 2.60 1.35   
High (Bachelor‘s degree/diploma or higher) 55 3.32 1.10   
Gender    0.36 0.551 
Male 65 2.89 1.30   
Female 72 2.88 1.31   
      
Risk Perception      
Age    3.22 0.075 
Young (≤ 44 years) 86 3.55 0.88   
Old (≥ 45 years) 51 3.25 0.91   
Education Level    5.04 0.026* 
Low (Grade 12 or lower) 82 3.28 0.99   
High (Bachelor‘s degree/diploma or higher) 55 3.67 0.69   
Gender    3.33 0.070 
Male 65 3.34 0.83   
Female 72 3.53 0.96   
      
Consumer Intentions      
Age    5.03 0.027* 
Young (≤ 44 years) 86 5.71 0.99   
Old (≥ 45 years) 51 5.14 1.55   
Education Level    6.85 0.010* 
Low (Grade 12 or lower) 82 5.24 1.40   
High (Bachelor‘s degree/diploma or higher) 55 5.88 0.88   
Gender    0.82 0.366 
Male 65 5.48 1.22   
Female 72 5.51 1.29   
Note. *p < 0.05, **p < 0.001   
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Environmental Concern: There is an effect of education level on environmental 
concern. As hypothesized, younger people (ages 44 and below) have a significantly (p = 0.016) 
higher score (M = 5.87) for environmental concern than older people (ages 45 and above) (M = 
5.29). The effect of education level on environmental concern however, is not significant at 95% 
confidence interval but is significant at 90% confidence interval (p = 0.065 < 0.1). People with 
less education (Grade 12 or lower) have lower scores for environmental concern (M = 5.46) than 
people with higher education level (Bachelor‘s degree/diploma) (M = 5.95). In the surveyed 
sample of population, environmental concern does not vary with gender.  
Self-estimated Knowledge: The results indicate that self-estimated/subjective 
knowledge of pharmaceutical pollution varies significantly (p = 0.003) by education level. 
People with higher education levels have significantly higher scores (M = 3.32) than those with 
less education (M = 2.60). Contrary to other parts of hypothesis, levels of self-estimated 
knowledge do not differ significantly by age or gender.    
Risk Perception: Similar to self-estimated/subjective knowledge, the levels of perceived 
risk scores vary significantly (p = 0.026) by education level. On average, people with higher 
education levels perceive pharmaceutical pollution as a significantly greater risk (M = 3.67) than 
people with lower education levels (M = 3.28). It is noteworthy that the effect of age (p = 0.075) 
and gender (p = 0.070) on risk perception however, are not significant at 95% confidence 
interval but are significant at 90% confidence interval (p < 0.100). Younger people (ages 44 and 
below) have higher score (M = 3.55) for risk perception than older people (ages 45 and above) 
(M = 3.25). Women (M = 3.53) have higher mean scores on risk perception scale than men (M = 
3.34).   
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Consumer Intention: The mean scores for consumer intention vary significantly by age 
and education level. On average, younger people (M = 5.71) have significantly (p = 0.027) 
higher environmentally-friendly consumer intentions than older people (M = 5.14). Also, people 
with higher education level (M=5.88) have a significantly (p = 0.010) higher score on consumer 
intention scale than people with lower education level (M = 5.24).  
Taken together, on average, people with higher education level have higher 
environmental concern, subjective knowledge, risk perception, and environmentally-friendly 
consumer intention than people with lower education level; younger people have higher 
environmental concern, risk perception and consumer intention scores than older people; and 
women have higher risk perception scores than men, according to the survey data. 
RQ 2(a):  Are environmental concern, awareness about pharmaceutical pollution, and 
perceived risk each individually associated with the dependent variable, environmentally-
friendly consumer intention (see Figure 14)? 
 
Figure 14: Research Question 2(a) 
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To examine RQ 2(a), the individual associations of each pair of independent variable and 
dependent variable (each IV-DV pair), i.e. environmental concern with consumer intentions; 
self-estimated knowledge with consumer intention; and risk perception with consumer intention, 
are each analyzed using general linear model (Figure 14). The results from individual analysis of 
each independent variable with the dependent variable are given in Table 7.  
Table 7 
 
Associations from General Linear Model analysis of each independent variable with 
dependent variable, consumer intention  
 R
2 
(adj.) df β SE β F P 
Model 1. Environmental 
Concern – Consumer 
Intention 
63.79% 1 0.81 0.05 238.81 0.000** 
Model 2. Self-estimated 
Knowledge – 
Consumer Intention 
14.51% 1 0.38 0.08 23.92 0.000** 
Model 3. Risk Perception 
– Consumer Intention 
47.00% 1 0.96 0.09 120.71 0.000** 
Note. *p < 0.05, **p < 0.001 
 
Model 1: Environmental Concern – Consumer Intention: Environmental concern had a 
significant positive association with consumer intentions, such that higher environmental 
concern indicated more environment-friendly consumer intentions. According to the data, 
environmental concern scores explained 63.79% of variance in consumer intention scores. An 
increase in 1 point on environmental concern was associated, on average, with an increase in 
0.81 points on consumer intentions scale.  
Model 2: Self Estimated Knowledge – Consumer Intention: Self-estimated knowledge, 
by itself, was also significantly (p = 0.000) positively associated with Consumer Intentions. 
However, it only explained 14.51% (R
2
 adj.) of the variance in Consumer Intentions, and a 1-
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point increase in score of self-estimated knowledge only resulted in a 0.37-point increase in 
consumer intentions.  
Model 3: Risk Perception – Consumer Intention: A significant (p = 0.000) positive 
association was found between risk perception and consumer intentions. Risk perception alone 
explained 47% (R
2
 adj.) of the variance in consumer intentions scores. A rise of 1 point in risk 
perception score was associated with 0.96 point rise in consumer intention score. 
RQ 2(b): Do age, education and/or gender moderate (i.e., have interaction effect on) the 
individual associations between the independent variable (environmental concern, self-estimated 
knowledge, risk perception) and the dependent variable (consumer intention) (see Figure 15)? 
 
Figure 15: Research Question 2(b) 
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The interaction effects of demographic variables (age, education level, and gender) on the 
associations of each independent variable with the dependent variable, i.e. environmental 
concern with consumer intentions; self-estimated knowledge with consumer intention; and risk 
perception with consumer intention, are each analyzed using a general linear model with 
stepwise backward elimination (Figure 15). The process of backward elimination for each model 
thus examined, resulted in the following significant interaction effects of demographic variables 
on each IV-DV pair presented in Table 8. 
Table 8 
 
General Linear Model analyses to test for interaction effects on associations between the 
independent variables and consumer intention 
Models R
2
 R
2 
(adj.) df Β SE β F p 
Model 1 67.14% 66.39%      
Environmental Concern   1 0.73 0.06 169.80 0.000** 
Education Level   1 1.08 0.33 10.66 0.001* 
Environmental 
Concern*Education Level 
  1 -0.16 0.06 8.66 0.004* 
        
Model 2  
No significant interactions were found 
        
Model 3 51.84% 50.75%      
Risk Perception   1 0.77 0.10 58.41 0.000** 
Education Level   1 1.20 0.37 10.65 0.001* 
Risk Perception*Education 
Level 
  1 -0.30 0.10 8.54 0.004* 
Note. Education level encoded as -1 (low education), +1 (high education) 
*p < 0.05, **p < 0.001       
 
Model 1: Interaction of Demographic Variables with Environmental Concern to Affect 
Consumer Intention: Of the three demographic variables, only education level was found to 
significantly interact (p = 0.004) with environmental concern to affect consumer intention (Table 
8). There was a positive effect of environmental concern on consumer intention scores for both 
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levels of education. However, the positive correlation was more pronounced for people with 
lower levels of education than for people with higher education level, as can be seen from the 
difference in slopes of the fitted line plots in Figure 16. This pronounced positive correlation is 
visible as a steeper slope of the fitted line plot between environmental concern and consumer 
intention for people with low education level. Thus, it can be observed that education level 
moderates the relationship between environmental concern and consumer intention.  
 
 
Figure 16: Interaction of Education Level with Environmental Concern to affect Consumer Intention 
Model 2: Interaction of Demographic variables with Self Estimated Knowledge to Affect 
Consumer Intention: None of the demographic by self-estimated knowledge interactions were 
significant in their effects on consumer intention. 
Model 3: Interaction of Demographic variables with Risk Perception on DV, Consumer 
Intention: Similar to interaction effects between environmental concern and consumer intention, 
Education Level 
Low (Grade 12 or below) 
High (Bachelor‘s degree/diploma or above)  
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only education level was found to moderate (p = 0.004) the association between risk perception 
with consumer intention (Table 8). There was a positive relationship of risk perception and 
consumer intention scores for both levels of education. However, the positive correlation was 
more pronounced for people with lower levels of education than for people with higher education 
level, as can be seen from the difference in slopes of the fitted line plots in Figure 17. This 
pronounced positive correlation is visible as a steeper slope of the fitted line plot between risk 
perception and consumer intention for people with low education level. Thus, it can also be 
observed that education level moderates the relationship between risk perception and consumer 
intention.  
 
  
Figure 17: Interaction of Education Level with Risk Perception to affect Consumer Intention 
In summary, as hypothesized, education level was observed to moderate associations 
between IV-DV pairs of environmental concern–consumer intention, and risk perception–
Education Level 
Low (Grade 12 or below) 
High (Bachelor‘s degree/diploma or above)  
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consumer intention. Contrary to the hypotheses, age had no significant moderator (interaction) 
effects on IV-DV pairs, and the self-estimated knowledge-consumer intention relation was not 
significantly moderated by any demographic variable.  
RQ 3:  Which among the three independent variables of environmental concern, 
awareness, and perceived risk, are the most salient indicators of environment-friendly consumer 
intentions (see Figure 18)?  
 
Figure 18: Research Question 3 
Consumer intention is associated with all three independent variables: environmental 
concern, self-estimated knowledge, and risk perception. The general linear model using 
standardized coefficients that regressed all three independent variables with the dependent 
variable consumer intentions (Figure 18), explained 71.19% (R
2 
adj.) of variance in consumer 
intention. From this model, it was indicated that environmental concern had the highest 
standardized regression coefficient among the three IVs (β = 0.75). Detailed values of all 
standardized coefficients from this model are given in Table 9. The standardized coefficients for 
self-estimated knowledge (β = -0.04) and risk perception (β = 0.45) are lower than that of 
environmental concern.   
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Table 9 
 
General Linear Model analysis of independent variables with dependent variable, consumer 
intention  
Model R
2
 R
2 
(adj.) Df β SE β T p 
 71.83% 71.19%      
Environmental 
Concern 
  1 0.75 0.07 10.60 0.000** 
Self-estimated 
Knowledge 
  1 -0.04 0.07 -0.54 0.588 
Risk Perception   1 0.45 0.87 5.17 0.000** 
        
Note. *p < 0.05, **p < 0.001  
Continuous Predictor Standardization: subtract the mean, then divide by standard deviation
      
 
It can be thus said that the most salient correlate of consumer intention score is 
environmental concern, as it has significant p-value and the highest standardized coefficient (β) 
in the model. Therefore, as hypothesized, environmental concern is most strongly associated 
with consumer intention among all three independent variables.  
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CHAPTER 4 
DISCUSSION 
The following sections discuss the findings of this research study, their interpretations, 
and their implications. In addition, the strengths and limitations of the study are discussed, along 
with possible directions that can be taken by future research.   
Summary of findings 
This study was conducted with the primary objective to understand perspectives of 
pharmaceutical consumers in India regarding environmental degradation caused by 
pharmaceutical contamination. Results from the survey suggest that people are concerned about 
the environment and are willing to make eco-friendly consumer choices. Survey results also 
indicate that although people are not extremely familiar with the phenomenon of pharmaceutical 
pollution, they do perceive it as an important risk (from RQ 1(a)). Young people have 
significantly higher scores on environmental concern and consumer intention than older survey 
participants; and people with higher levels of education have significantly higher scores on self-
estimated knowledge, risk perception, and consumer intention than people with lower levels of 
education (from RQ 1(b)). Results indicate the people demonstrate positive associations between 
environmental concern and consumer intention, self-estimated knowledge and consumer 
intention, and risk perception and consumer intention (from RQ 2(a)).  Moderator analyses 
indicated that people with high education level also show a significantly stronger correlation 
between environmental concern and consumer intention, and risk perception and consumer 
intention, than people with low education level (from RQ 2(b)). In addition, evidence indicates 
that people who are more concerned about the environment, have more knowledge about 
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pharmaceutical pollution, and consider it a greater risk, are overall more willing to engage in 
eco-friendly consumerism. Results also suggest that environmental concern is the strongest 
indicator of environmentally-friendly consumer intention among survey participants (from RQ 
3). 
Relationship between environmental concern and pro-environmental behavior, 
attitudes, or behavior intention: In recent studies, environmental concern has been observed to 
be a strong indicator of environmentally responsible behavior, attitudes, or behavior intention 
(Lee 2008, 2014; Mobley et al., 2010; Yeung, 2004). These studies found significant positive 
correlations between environmental concern and environmentally responsible behavior (Mobley 
et al., 2010); attitudes towards the natural environment (Yeung, 2004); and behavior intentions 
for sustainable consumption (Lee, 2008, 2014).  Likewise, in this study, environmental concern 
was also found to be the strongest indicator of environmentally-friendly consumer intention, a 
sign of potential pro-environmental behavior. For this study, environmental concern is defined as 
an affective attribute of an individual to care for the environment, including emotional 
involvement with the environment. Several studies have illustrated the defining role of emotional 
involvement in pro-environmental behavior (Bang et al., 2000; Grunert, 1993). The current study 
also includes items that examine emotional concern (see Appendix A1) as part of the 
environmental concern measure. However, the strong correlation between environmental 
concern and behavior, attitudes, or behavior intention is seen only in recent studies. In multiple 
studies conducted during the 1990s, the relationship between environmental concern and 
ecological behavior (pro-environmental behavior) was found to be mostly either moderate or 
weak (Kaiser et al., 1999). These earlier studies defined environmental concern as ―attitude 
towards the environment, comprising knowledge, values, and intention‖ (Kaiser et al., 1999) – 
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while excluding emotional concern from the measures. The substantial difference in the report of 
correlation between environmental concern and ecological behavior among new and old research 
studies can therefore, in the author‘s opinion, be attributed to the change in the definition of 
environmental concern over the years.    
Associations between environmental knowledge and behavior or behavior intention: 
According to the knowledge deficit model, the gap between a non-expert individual‘s (or 
layperson‘s) perception of a hazard and the actual risk posed by the hazard is a consequence of 
the person‘s lack of knowledge (Slovic, 1987). In addition, it has been found that when an 
individual‘s knowledge about an issue is inadequate, the person is more likely to trust an expert 
(Giddens, 1990).  However, in the current study, it was observed that although individuals did 
not have much knowledge about the subject of pharmaceutical pollution, they still considered it a 
hazard.  Vandermoere (2008) studied residents‘ subjective and objective knowledge with respect 
to soil contamination and found that the increase in knowledge resulted in increased hazard 
perception and awareness, which was linked closely to residents‘ willingness to act. Similarly, 
this thesis has illustrated that increase in subjective knowledge is correlated with in an increase 
in individual‘s willingness to engage in environmentally-responsible consumerism.     
Risk perception studies: Risk perception studies are important because governments, 
policymakers, and industrialists need to account for public opinion when implementing decisions 
that directly affect people and their environment (Huang et al., 2013).  A single quantitative 
measure of perceived risk from a hazard was developed by Slovic (1987) that included attributes 
of familiarity, severity, benefits, etc. Studies have observed a significant relationship between 
risk perception and behavior, such that perceived risk is positively correlated with the 
willingness to take pro-environmental action (Gifford & Nilsson, 2014; Stern, Dietz, Kalof & 
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Guagnano, 1995). Reflecting the findings in previous literature, the current study also 
demonstrates a significant positive relationship between perceived risk and environmentally-
friendly consumer intention.  
Relationship between behavior intention and the actual behavior: Both the theory of 
reasoned action (Ajzen & Fishbein, 1980), and the theory of planned behavior (Ajzen, 1985), 
conclude that a behavior is immediately preceded by the intention to perform that behavior, i.e., 
an action is preceded by the intention to act. This theory has been used in many studies regarding 
ecological behavior (Hensen et al., 2016; Kaiser et al., 1999; Steg & Vlek, 2009; Vermeir & 
Verbeke, 2006) as it is logistically easier to measure self-reported behavior intention than to 
measure actual behavior. A meta-analysis (Schwenk & Möser, 2008) of 11 studies that measured 
environmental behavior intention and actual environmental behavior found that there was a 
substantial correlation between intention and behavior. The authors, however, also 
acknowledged the possible influence of confounding situational factors. For the current research 
study, it can thus be inferred that there is a fair likelihood of translation of consumer intention to 
actual consumer action or behavior.   
Strengths 
This study has several strengths. First, the survey questionnaire was composed of valid 
and reliable measures. All measures have high internal consistency (with Cronbach alpha values 
from 0.79 to 0.94) and were validated in previous literature in different settings.  The sample for 
this study, although not completely randomly selected, is expected to be fairly representative of 
the population of the city of Indore, India. The setting of the study, a pharmacy, was chosen as its 
customers came from a variety of age, gender and educational level. The study also uses Likert, 
or Likert-type scales for all the constructs. Likert scales are considered one of the best ways to 
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study people‘s perceptions and can be used to conduct a variety of statistical tests as they are 
interval scales.  
Second, the conclusions drawn in the study are based on General Linear Model rather 
than basic regression to overcome assumptions regarding normal distribution, homogeneity of 
variance, and the distinction between continuous factors and covariates. Tests for non-
collinearity of variables was conducted early in the study, and pilot tests were conducted to test 
statistical assumptions. Suitable models and procedures were suggested by professional statistics 
consultants throughout the course of this research.  
Third, the study filled various gaps in the existing body of literature. The study is the first 
of its kind, to the best of author‘s knowledge, to test the variables together in context of 
pharmaceutical pollution, especially in India. Though there are studies researching pro-
environmental behavior regarding drug take-back programs, perception studies about willingness 
to consume sustainable pharmaceuticals have not been conducted. The current literature on 
pharmaceutical pollution in India mostly consists chemical concentration analyses, and case 
studies and reports of the affected population. Very little information is available on the wider 
public perception about the issue. The study is extremely relevant to the current time, as the 
country is planning to expand its pharmaceutical industry while extensively being polluted by the 
industry at the same time. The study explores interactions and influencing variables that affect 
decision-making, in order to identify the most useful points of intervention. Understanding these 
relationships contributes to filling the gap in literature on pro-environmental behavior as it 
relates to pharmaceutical drug consumption.  
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Limitations 
The limitations of this study are organized by the four types of validity in the following 
text.  Despite the limitations mentioned in this section, the study demonstrates promising results 
that are expected to promote future research on Indian consumers‘ perceptions regarding 
environmental pollution due to pharmaceutical contamination.   
Internal validity: This study was designed as a non-experimental study, and thus it 
cannot conclude a causal relationship between the independent variables and the dependent 
variables. The study can only conclude associations or correlational relationships between the 
IVs and the DV. Since there is no direct manipulation of the levels of independent variables, the 
direction of dependence can also be questioned. Also, apparent correlational relationships can be 
driven by confounding variables like social or personal factors.  
 Furthermore, an alternative explanation for higher-than-expected scores of the surveyed 
population on knowledge and environmental concern is the prevalence of cleanliness campaigns 
in Indore city. As a part of Swachh Bharat Abhiyan (Clean India Mission), the city has many 
active citizen engagement and awareness initiatives, which might have resulted in higher scores 
on subjective knowledge and environmental concern than expected by the author.      
External validity: The conclusions of this study may not be generalized to all Indian 
people regarding pharmaceutical pollution. Since the sample was derived from a single city, it 
may also not be considered to represent views of citizens of another city in India. Also, as the 
sample size of this study was relatively small (n = 137), it cannot be extended to represent the 
perceptions of all citizens of Indore. The effect of setting of the study should be acknowledged. 
Due to the subject of the study, it is possible that the results were influenced by the pharmacy 
setting in which data collection occurred. The results obtained in this study may or may not be 
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replicated if the same study is conducted in a different setting, for example, a mall. Similarly, it 
is possible that the results are not replicated if a different sample of the population is surveyed.    
Construct validity: An important possible limitation of this study is that all measures 
were translated from English to Hindi (see Appendix A for both versions). The possible loss of 
meaning in translation could have led to unintentional inaccuracy, or misunderstandings and 
misinterpretations regarding true meaning of questions, even though attempts were made to 
minimize this by using back-translation and the presence of a research assistant who 
administered the survey. For all constructs, reliability was measured using Cronbach alpha, but 
data was not available regarding test-retest reliability for calculation of Pearson product-moment 
correlation coefficient.  Additionally, all measure used self-report, causing a methodological 
overlap, causing shared method variance leading to mono-method bias which threatens construct 
validity. 
Experimenter effect could be a limitation of this study because conducting surveys is not 
a very common form of data collection in India. Specifically, as the survey was administered by 
a research assistant, the presence of experimenter might have encouraged people to answer in 
more socially-acceptable ways, confirming to subjective norms. Experimenter effect could have 
been further compounded by the fact that the research assistant was an employee of the 
pharmacy and dressed in staff uniform. Evaluation apprehension could have also influenced the 
participants‘ responses, causing them to provide socially desirable or politically correct answers.  
Question framing is a potential drawback of this study – many items in the scales used 
affirmative language that could lead to agreement bias.  
Statistical validity: The small sample size of the study has implications for statistical 
validity. The sample size was inadequate to perform higher order statistical analyses, including 
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tests for three-way interaction effects. In addition, the data was collected at the level of an 
individual, so conclusions cannot be drawn at the community, city, state, or country level.    
Implications and potential applications 
The study collects preliminary evidence that indicate the possibility of strong consumer 
support in the transition to environmentally-friendly drugs, especially in a developing country. If 
replicated across the country, the findings of this study would provide enough consumer support 
to encourage the production and marketing of sustainable pharmaceuticals in India.  
A nuanced understanding of people‘s environmental concern, knowledge, and risk 
perceptions is also achieved through this study, and can be leveraged to raise awareness and 
gather popular support for action against pharmaceutical pollution in the country. Approaches for 
minimizing pharmaceuticals in the environment need public awareness and support for their 
successful implementation. Perception studies like this research help to ascertain the disposition 
of stakeholders. This research provides quantitative information about behavior change among 
consumers and potential barriers to implementation of planned strategies. A good understanding 
of stakeholder disposition would help activists and policymakers to gather support for their 
activities. Perception studies can also be combined with existing data on regional chemical 
contamination, presenting a complete picture of the issue in conformance with the cause-and-
effect bidirectionality in human-environment relations. Such comprehensive reports could then 
be used to develop policies, agendas, and guidelines for the upcoming pharmaceutical industries.  
Findings of this study can be shared with policymakers, pharmaceutical manufacturers 
and researchers, environmentalists, citizen‘s collectives, and other social science researchers. 
The study can also be shared with medical practitioners, hospital staff, pharmacists, and the 
patients or other end users of pharmaceutical products. Finally, this study can be shared with the 
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general population and community at large to raise awareness about pharmaceuticals in the 
environment. 
Future research 
The fields of pharmaceuticals in the environment (PiE) and sustainable pharmaceuticals 
are still considered ―emerging‖ fields (Kümmerer, 2004, Chapter 33), hence, there are many 
suggested directions for future research. In the context of this research thesis, future studies can 
be conducted that administer the same questionnaire in a different setting, at a different location, 
or to a bigger and more randomized sample. Such replication studies would help to determine the 
internal validity of conclusions drawn in the study.  
Additionally, the study can be strengthened by measuring potential confounding variables 
like socio-economic status, education level, age, profession, place attachment, background of 
environmental education, development in a region, and quality of life. Gifford & Nilsson (2014) 
give a list of 18 social and personal factors that influence ecological concern and behavior, 
including childhood experience, personality and self-construal, sense of control, values, political 
and world views, goals, felt responsibility, cognitive biases, religion, urban–rural differences, 
social class, proximity to problematic environmental sites. Future research can aim to measure 
the influencing factors and their moderating or mediating effects on environment concern and 
behavior.   Different stakeholders including doctors, pharmaceutical manufacturers and 
distributors, pharmacists, experts, chemistry researchers, environmentalists, policymakers, urban 
planners and developers, infrastructure engineers, and people suffering from ailments or living in 
close proximity to areas that suffer ecological damage due to pharmaceuticals can be selectively 
included in the study to understand various critical perspectives.  
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Future studies can change the design of the research. Multiple measures can be used to 
measure the same constructs to strengthen construct validity. Experimental designs can be 
developed, with objective knowledge about pharmaceutical pollution as the predictor 
independent variable. New scales and measures can be developed that are specific to the issue of 
pharmaceuticals in the environment, instead of general environmental scales. All scales used in 
this study can potentially be modified such that pharmaceutical pollution or eco-friendly 
pharmaceuticals are directly implicated in the questions. Future research can also diversify the 
techniques used for data collection. This study uses survey questionnaires, but other objective 
measurements like interviews and behavioral observation studies can also be conducted within 
the same framework. Other quantitative survey models like Knowledge, Attitude and Practice 
(KAP) models can be used in similar settings in the context of pharmaceutical contamination.  
Future research can also be a combination of perception studies, chemical analysis 
studies, and sustainable pharmaceutical alternatives. For example, in a given geographic area, 
chemical analyses can be conducted to test for the presence of specific pharmaceutical 
compounds in water and soil.  Information about people‘s perceptions of the issue and 
sustainable alternatives of pharmaceuticals identified in the environment can be compiled 
together with the chemical analyses. This compilation can then be used by the relevant policy-
making body to take well-informed and holistic decisions to address environmental 
contamination, targeted at the most prevalent or toxic pharmaceuticals.  
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Conclusion 
This study examined the effect of environmental concern, self-estimated knowledge, and 
risk perception about pharmaceutical pollution on consumer intention to purchase 
environmentally-friendly pharmaceuticals in Indore, India. Since these are personal covariates, 
the demographic variable of education level had a significant impact on some of these 
relationships. Results suggest that people are concerned about environmental pollution, 
considering it a major risk, and support environmentally-friendly consumer behavior. Findings 
from this study can help advance our understanding of people‘s perceptions about environmental 
degradation and ecopharmacology in developing countries like India that are emerging as strong 
competitors in the global pharmaceutical market. The inferences from this study can be used by 
industrial manufacturers, conservationists, activists, and policymakers to take respective relevant 
actions to develop holistic long-term solutions that address pharmaceutical pollution in India.  
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APPENDIX A1: SURVEY QUESTIONNAIRE (ENGLISH) 
Perceptions of Indian Consumers towards Pharmaceuticals in the Environment 
Survey Response #_________  
 
Part A: Consumption of Pharmaceuticals 
Please tell me what medicines have you consumed during the last two days. Do you consume 
these medicines daily or weekly (used regularly), or do you use them occasionally (as 
needed)?   
1. Medicines consumed during the 2 days preceding the survey (select all that 
apply) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Medicine Used 
Continuously 
Used 
Occasionally 
Vitamins + Mineral Supplements (e.g., Vit C, 
Becosule, Supradyn) 
  
Nsaids (e.g., Ibuprofen, Naproxen)   
Analgesics (e.g., Paracetamol, Contramol)   
Antibiotic (e.g., Cefuroxime, Linezolid)   
Antianemia Preparations (e.g., Folvite, Fefol)   
Antacids (e.g., Pantocid, Famocid)   
Antihistamines (e.g., Levocetirizine, 
Chlorpheniramine Maleate) 
  
Cough and Cold Preparations (e.g., Corex, 
Benadryl) 
  
Topical Products for Muscular Pain (e.g., 
Moov, Ice Gel) 
  
Laxatives (E.G., Smooth, Chromaffin)   
None  
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Part B: Environmental Concern 
Hand “Parts B + E” answer card to respondent. 
Now I will read some statements about protection of nature and environment. After each 
statement, please indicate how much you agree or disagree with the statement.  Please refer 
to the card marked “Part B + E”; the response options are “strongly disagree” “disagree” 
“slightly disagree” “neutral” “slightly agree” “agree” and “strongly agree.” There are no right 
or wrong answers, please indicate your own opinion. 
2. Environmental Concern Scale 
 
So now I would like to tell you something. The medicines that we consume dissolve in water 
as they go through our bodies, and end up going into rivers and ponds. Due to the presence 
of medicines in water and soil, other animals come into contact with them. Some chemicals 
making up these medicines are harmful to these organisms, and to the environment.  
 Strongly 
Disagree 
(1) 
Disagree 
(2) 
Slightly 
Disagree 
(3) 
Neutral 
(4) 
Slightly 
Agree 
(5) 
Agree 
(6) 
Strongly 
Agree 
(7) 
I am worried about the worsening 
of the quality of India’s 
environment.  
       
I am worried that our pollution 
problem is getting worse.  
       
I cherish our earth very much.         
I fully support environmental 
protection.  
       
It’s very important to advocate 
green living in India.  
       
Environmental protection is one of 
my major concerns.  
       
I fully support to have more 
environmental activities organized 
in India.  
       
I regard myself having a 
responsibility to protect the 
environment.  
       
I am emotionally involved in 
environmental protection issues in 
India. 
       
I think about how the 
environmental quality in India can 
be improved.  
       
I think it is very important to 
advocate environmental protection 
to Indian citizens.  
       
I totally agree with the statement 
that “environmental protection 
starts with me." 
       
81 
 
Part C: Awareness about Pharmaceutical Pollution (Self-estimated Knowledge about 
Pharmaceutical Pollution) 
Now I will read some questions about your knowledge regarding pharmaceutical pollution. 
After each question, please look carefully at the scale given below and tell me your answer. 
There are no right or wrong answers, please indicate your own opinion. 
3. To what extent do you feel informed about the problem of pharmaceutical 
pollution? (check one box) 
 
Not at all 
(1) 
 
(2) 
 
(3) 
 
(4) 
Very much 
(5) 
     
 
4. To what extent do you feel informed about the problem in comparison with 
other residents? (check one box) 
Less 
informed 
(1) 
 
 
(2) 
 
 
(3) 
 
 
(4) 
Better 
informed 
(5) 
     
 
5. To what extent do you feel informed about pharmaceutical pollution in India? 
(check one box) 
Not at all 
(1) 
 
(2) 
 
(3) 
 
(4) 
Very much 
(5) 
     
 
6. To what extent do you feel informed about the pharmaceutical pollution in India 
in comparison with other residents? (check one box) 
Less 
informed 
(1) 
 
 
(2) 
 
 
(3) 
 
 
(4) 
Better 
informed 
(5) 
     
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Part D: Perceived Risk from pharmaceutical pollution 
Now I will read some statements regarding your knowledge about pharmaceutical pollution. 
After each statement, please look carefully at the scale given below and tell me your answer. 
There are no right or wrong answers, please indicate your own opinion. 
7. Is the risk of pharmaceutical pollution new and unfamiliar, or is it old and 
familiar? 
Unfamiliar 
(1) 
 
(2) 
 
(3) 
 
(4) 
Familiar 
(5) 
     
 
 
8. How much knowledge do you have of the risk of pharmaceutical pollution? 
No 
knowledge 
(1) 
 
 
(2) 
 
 
(3) 
 
 
(4) 
High level of 
knowledge 
(5) 
     
 
9. How beneficial to local economic development is the pharmaceutical industry? 
Not 
beneficial 
(1) 
 
 
(2) 
 
 
(3) 
 
 
(4) 
Highly 
beneficial 
(5) 
     
 
10. Will the effects of the risk of pharmaceutical pollution occur immediately, or will 
they take place in the future? 
 
Will occur 
immediately 
(1) 
 
 
 
(2) 
 
 
 
(3) 
 
 
 
(4) 
Will occur far 
in the future 
(5) 
     
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11. How many people are subjected to the risk of pharmaceutical pollution 
throughout all of India? 
Very few 
(1) 
 
(2) 
 
(3) 
 
(4) 
Quite a few 
(5) 
     
 
12. When the risk of pharmaceutical pollution appears, how fatal will the 
consequences be? 
Non-fatal 
(1) 
 
(2) 
 
(3) 
 
(4) 
Very fatal 
(5) 
     
 
13. To what degree can the risk be avoided by the exposed population? 
Not at all 
(1) 
 
(2) 
 
(3) 
 
(4) 
Completely 
(5) 
     
 
14. To what degree do you trust in the government or related policy makers’ risk 
management abilities? 
Do not trust 
at all 
(1) 
 
 
(2) 
 
 
(3) 
 
 
(4) 
Completely 
trust 
(5) 
     
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Part E: Consumer Intentions 
Respondent should look at the “Parts B + E” answer card again. 
Great.  We’re almost done.  Now I’d like to know about your purchasing trends. I will read 
statements about purchasing products. After each statement, please look at the card 
(labelled “Parts B + E”) and tell me how much you agree or disagree with the statement.  The 
response options are: “strongly disagree” “disagree” “slightly disagree” “neutral” “slightly 
agree” “agree” and “strongly agree.”    There are no right or wrong answers, please indicate 
your own opinion. 
15. Consumer Intentions (Select one option for each statement) 
 
 Strongly 
Disagree 
(1) 
Disagree 
(2) 
Slightly 
Disagree 
(3) 
Neutral 
(4) 
Slightly 
Agree 
(5) 
Agree 
(6) 
Strongly 
Agree 
(7) 
 I feel a personal sense of 
responsibility for the 
environment.  
       
I feel accountable for the 
environmental impact of my 
purchases. 
       
I think it is appropriate, for me 
as a single person, to buy 
products only after considering 
their environmental impact.  
       
When searching for a product i 
should seek a balance between 
its costs and its impact on the 
environment. 
       
I am willing to make personal 
sacrifices for the good of the 
environment. 
       
 I carry responsibility for the 
environmental impact of my 
purchases on society.  
       
I need to help maintaining a 
green environment for society. 
       
In my service to society I should 
balance short-term personal 
goals with long-term 
environmental goals. 
       
I feel responsible for the 
environmental impact of my 
purchases on future generations.  
       
I need to help maintain a green 
environment for future 
generations. 
       
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Part F: Demographic Data 
Now I have just three final questions about you. 
16. What is your age (in years)? 
 18-24 
 25-34 
 35-44 
 45-54 
 55-64 
 65-74 
 75-84 
 >85
17. Educational Level 
 No schooling 
 Primary 
 Secondary 
 Post-secondary 
 Tertiary 
 Post-graduate
 
18. Gender 
 Female 
 Male 
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APPENDIX A2: SURVEY QUESTIONNAIRE (HINDI TRANSLATED) 
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   अ                      /                इ        ,                      
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          )  
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(3) 
 
 
(4) 
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                  ? (                   ) 
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(2) 
 
 
(3) 
 
 
(4) 
     
      
(5) 
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(                   )  
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(4) 
        
(5) 
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(2) 
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 अ                   अ             
 
32.        (      )     ? 
 18-24 
 25-34 
 35-44 
 45-54 
 55-64 
 65-74 
 75-84 
 >85 
 
33.         
                  
        
       
          
      
         
 
34.     
    
     
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